Table 1 Summary of patients characteristics at treatment start.
From: Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy
Number of patients | 45 | |
|---|---|---|
Age [years] (median and range) | 72 [57-81] | |
Stage T | T1c | 22 (49%) |
T2a-c | 17 (38%) | |
T3a-b | 6 (13%) | |
Stage N | N0 | 43 (96%) |
N1 | 1 (2%) | |
Nx | 1 (2%) | |
Stage M | M0 | 45 (100%) |
M1 | 0 (0%) | |
Gleason score | 6 | 25 (56%) |
7 | 20 (44%) | |
PSA at staging (μg/l) (Median and range) | 10.0 [4.7, 33.8] | |
Hormonotherapy | Yes | 31 (69%) |
No | 14 (31%) | |
Surgery | Yes | 2 (4%) |
No | 43 (96%) | |
Dose Prescription: | ||
Group A | 70+6 Gy | 7 (16%) |
70+8 Gy | 9 (20%) | |
Group B | 78 Gy | 29 (64%) |